Suicidal Ideation: Clinical Trials

39 trials for Suicidal Ideation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 completed, 10 recruiting, 6 terminated, 6 withdrawn. 39 Phase 2, 9 Phase 3, 4 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 239Completed 10, Recruiting 10, Terminated 6, Withdrawn 6, Unknown 4, Not yet recruiting 2, Active not recruiting 1
Phase 39Terminated 3, Completed 2, Recruiting 2, Active not recruiting 1, Unknown 1
Phase 14Completed 2, Terminated 1, Withdrawn 1

Follow Suicidal Ideation: new trials by email Literature Review of Suicidal Ideation trials Research Report on Suicidal Ideation

Trials (filtered) newest first · largest first

All 39 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Intravenous Ketamine for Acute Suicidal Crisis and Psychiatric Hospital Length of Stay
Esketamine, Midazolam (Intravenous) - Suicidal Ideation, Suicidal Behavior
Phase 2Not yet recruitingUniversity of Sao Paulo1062027-04-302026-10-22
Assessing of Behavioral Risk and Response to Electromagnetic and Psychedelic Therapies
Transcranial Magnetic Stimulation, Psilocybin (drug), Neurofeedback - PTSD, PTSD - Post Traumatic Stress Disorder
Phase 2Not yet recruitingUniversity of New Mexico1502026-12-312026-10-30
Alleviating Suicidality by Combining Psychotherapy and IM Ketamine for Rapid Treatment in the Emergency Department
Ketamine Injectable Solution, Placebo Injection, Crisis Response Plan - Suicidal Ideation
Phase 2RecruitingThe University of Texas Health Science Center at San Antonio2002026-09-302026-10-15
Inhaled DMT for Major Depressive Disorder
N,N-Dimethyltryptamine (15 mg + 60 mg), N,N-Dimethyltryptamine (1 mg + 4 mg) - MDD, Major Depressive Disorder (MDD)
Phase 2RecruitingUniversidade Federal do Rio Grande do Norte1402026-08-012026-07-13
Ketamine With Dialectical Behavioural Therapy (DBT) for Suicidality in Individuals With Treatment-Resistant Depression and Borderline Personality Disorder (KET-DBT)
Ketamine Hydrochloride, Midazolam Hydrochloride, Dialectical Behavioral Therapy (DBT) - Borderline Personality Disorder (BPD), Treatment-Resistant Major Depressive Disorder
Phase 2RecruitingJoshua Rosenblat1202026-07-162026-07-29
Precision Phenotyping of Behavioral Risk and Response to Electromagnetic and Psychedelic Therapies
fMRI Neurofeedback, Accelerated theta burst stimulation, Psilocybin assisted therapy - Suicidal Ideation
Phase 2WithdrawnUniversity of New Mexico2026-05-012026-03-20
Sleep Health in U.S. Marines
Sleep Leadership, Circadian, Light, and Sleep Skills in Shipboard Military (CLASS-MC) Personnel Program, Insomnia Coach - Depression, Suicidality
Phase 2RecruitingSan Diego State University8602026-03-312026-04-16
N2O for Acute Suicidality and Depression in the ED
Nitrous oxide gas for inhalation, Placebo - Suicidal Ideation, Major Depressive Disorder
Phase 2WithdrawnUniversity of Chicago2026-02-272026-03-04
Acceptability & Safety of Two Sequential Doses of Psilocybin in Bipolar Disorder II Depression and Suicidality
Psilocybin, Therapeutic Support - Bipolar II Disorder, Depression, Bipolar
Phase 2RecruitingThe University of Texas Health Science Center, Houston102025-07-072026-08-12
Understanding and Treating Suicidal Ideation With Ketamine
ketamine hydrochloride - Suicidal Ideation, Major Depressive Disorder (MDD)
Phase 2 / Phase 3RecruitingThe Royal's Institute of Mental Health Research362025-04-082026-11-09
Nitrous Oxide in the Treatment of Acute Suicidal Ideation
50% N2O plus 50% O2, Oxygen (O2) - Suicidality, EEG
Phase 2RecruitingUniversity of Zurich852025-01-132025-01-16
Low Amplitude Pulse Seizure Therapy Versus Standard Ultra-Brief Right Unilateral Electroconvulsive Therapy
Sigma-Stim, RUL LAP-ST (Low-Amplitude Pulse Seizure Therapy - Right Unilateral) - Suicidal Ideation, Major Depressive Disorder
Phase 2 / Phase 3Active not recruitingMichigan State University302024-07-032026-11-02
SAINT for MDD in an Inpatient Setting Follow-on
Active SAINT Stimulation, Sham SAINT Stimulation - Major Depressive Disorder, Major Depressive Episode
Phase 2 / Phase 3TerminatedMagnus Medical22024-06-302025-03-24
The Effects of SAINT® Neuromodulation System on Explicit and Implicit Suicidal Cognition
Active SAINT Stimulation, Sham SAINT Stimulation - Major Depressive Disorder, Major Depressive Episode
Phase 2 / Phase 3TerminatedMagnus Medical22024-06-302025-03-24
Ketamine for OUD and Suicidal Ideation in the ED
Ketamine, Saline Solution - Opioid Use Disorder, Suicidal Ideation
Phase 2TerminatedBrigham and Women's Hospital42024-06-142025-04-08
Treatment of Suicidal Ideation in the Emergency Department Using Nitrous Oxide
Nitrous oxide, Medical air - Suicidal Ideation, Emergency Psychiatric
Phase 2UnknownUniversity Hospital, Tours302024-06-012024-06-07
iTBS+D-Cycloserine for Youth Suicide
D-Cycloserine, intermittent Theta-Burst-repetitive Transcranial Magnetic Stimulation, Placebo oral tablet - Suicidal Ideation, Suicide, Attempted
Phase 2RecruitingUniversity of Calgary542024-03-112024-11-12
The Impact of AMPA Receptor Blockade on Ketamine's Anti-Suicidal Effects
Perampanel 6 MG, Ketamine, Placebo - Depressive Disorder, Major Depressive Disorder
Phase 2RecruitingYale University302023-04-032026-05-06
Ketamine & Crisis Response Plan for Suicidal Ideation in the ED
Ketamine Hydrochloride, Crisis Response Plan - Suicide
Phase 2 / Phase 3RecruitingThe University of Texas Health Science Center at San Antonio242023-01-062026-09-30
Ketamine Infusion for Rapid Reduction of Suicidality in Pediatrics
Ketamine Injectable Solution, Midazolam Injectable Solution, Normal Saline 0.9% Injectable Solution - Suicidal Ideation
Phase 1 / Phase 2TerminatedUniversity of British Columbia152022-06-012024-12-18

Showing 20 of 39. Sign in to see all of them.

Narrower conditions

Depression (16)  ·  Depressive Disorder, Major (13)  ·  Suicide (10)  ·  Bipolar Disorder (8)  ·  Suicide, Attempted (5)  ·  Depressive Disorder, Treatment-Resistant (3)  ·  Emergencies (3)  ·  Stress Disorders, Post-Traumatic (3)  ·  Depressive Disorder (2)  ·  Mental Disorders (2)  ·  Mood Disorders (2)  ·  Self-Injurious Behavior (2)  ·  Anxiety Disorders (1)  ·  Behavior (1)

Broader conditions

Behavior (38)  ·  Behavioral Symptoms (38)  ·  Self-Injurious Behavior (37)  ·  Suicide (29)  ·  Mental Disorders (20)  ·  Mood Disorders (16)  ·  Depressive Disorder (11)  ·  Bipolar and Related Disorders (8)  ·  Disease Attributes (3)  ·  Pathologic Processes (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Stress Disorders, Traumatic (3)  ·  Trauma and Stressor Related Disorders (3)  ·  Chemically-Induced Disorders (2)  ·  Narcotic-Related Disorders (1)

Interventions

Ketamine (12)  ·  Lurasidone Hydrochloride (3)  ·  Midazolam (3)  ·  Psilocybin (3)  ·  Cycloserine (2)  ·  Nitrous Oxide (2)  ·  Saline Solution (2)  ·  Therapeutics (2)  ·  Air (1)  ·  Endothelium-Dependent Relaxing Factors (1)  ·  Esketamine (1)  ·  Inhalation (1)  ·  Injections (1)  ·  Light (1)  ·  Music Therapy (1)

Sponsors

NeuroRx, Inc. (3)  ·  Magnus Medical (2)  ·  The University of Texas Health Science Center at San Antonio (2)  ·  The University of Texas Health Science Center, Houston (2)  ·  University of New Mexico (2)  ·  Boston Children's Hospital (1)  ·  Brigham and Women's Hospital (1)  ·  Icahn School of Medicine at Mount Sinai (1)  ·  Joshua Rosenblat (1)  ·  Marijn Lijffijt, PhD (1)  ·  Michigan State University (1)  ·  New York State Psychiatric Institute (1)  ·  Novartis Pharmaceuticals (1)  ·  Oui Therapeutics, Inc. (1)  ·  San Diego State University (1)

Countries

United States (27)  ·  Canada (5)  ·  Brazil (3)  ·  Argentina (1)  ·  China (1)  ·  France (1)  ·  Germany (1)  ·  Japan (1)  ·  Malaysia (1)  ·  Mexico (1)  ·  Netherlands (1)  ·  Poland (1)  ·  Russia (1)  ·  Spain (1)  ·  Switzerland (1)

Top investigators

Brandon Bentzley, MD (2)  ·  Aimee Moulin, MD (1)  ·  Alan Peterson, PhD, ABPP (1)  ·  Alexander McGirr, MD PhD (1)  ·  Andrew A Nierenberg, MD (1)  ·  Andrew Nierenberg, MD (1)  ·  Cheryl McCullumsmith, MD PhD (1)  ·  Daniel C Javitt, MD (1)  ·  Davin Quinn, MD (1)  ·  Emily Schmied, PhD (1)  ·  Jennifer Phillips, PhD (1)  ·  John R Knight, MD (1)  ·  Jonathan C Javitt, MD, MPH (1)

Results publications

PMID 29202655, PMID 32785636, PMID 33318635, PMID 33583341, PMID 33825765, PMID 34149476, PMID 35110300, PMID 35735167, PMID 36776623, PMID 37573534, PMID 39714786, PMID 39915491, PMID 40669910, PMID 40779267, PMID 41545765, PMID 42138588, PMID 42234079, PMID 42442821, PMID 42477489

NIH funding

KL2TR003168 (1), R01MH107183 (1), R01MH125160 (1), R42MH123357 (1), UL1TR002645 (1)